Delivery Order SPE2DB22D3301-SPE2DB25FY7TH
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $2,184.32 firm fixed price delivery order by the Defense Logistics Agency (DLA) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract covers the supply of Triescence 40 mg/mL vials, a pharmaceutical product supporting federal medical procurement needs. This delivery order was competitively awarded with no set-aside designation and is performed...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Triescence 40 mg/ml vials, with a ceiling value of $2,392.94 and completion deadline of September 2, 2025. This non-competitive delivery order represents a firm fixed-price procurement utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a $999.9 billion prime vendor agreement...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $16,589.43 by the Defense Logistics Agency's Medical Supply Chain on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $5,546.88 on September 13, 2025, by the Defense Logistics Agency's Medical Supply Chain. This non-set-aside contract, which is scheduled for completion by September 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The company will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $744,629.90 on September 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 15, 2025, operates as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,097.32 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside delivery order operates under firm fixed pricing and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The work will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,791.72 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on August 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,440 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 19, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $5,287.68 by the Defense Logistics Agency's Medical Supply Chain on July 26, 2025. This competitively awarded, firm fixed-price contract is classified as a child order and carries an ultimate completion date of July 28, 2025. The award represents a small-value transaction typical of the company's extensive federal medical procurement activities supporting military and veteran...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $33,186.00 from the Defense Logistics Agency's Medical Supply Chain division on September 29, 2025. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by September 30, 2025. The award carries no set-aside designation, indicating it was competed among eligible vendors in the open market. This...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY7THDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Trisenece 40 mg/ml vials, valued at $5,868.59. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set for ultimate completion on July 15, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The Trisenece order represents a routine fulfillment under the company's comprehensive global pharmaceutical support vehicle, which enables supply of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 7/14/25 |